Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Am J Gastroenterol. 1996 Apr;91(4):754-8.
This study was conducted to clarify the characteristics of patients with extrahepatic primary cancers (EHPC) associated with hepatocellular carcinoma (HCC), as well as to investigate the influence of EHPC on both patient survival and disease-free survival after hepatic resection.
Forty-one of 463 patients who underwent hepatic resection were included. The clinicopathological factors, including survival, were compared between patients with and without EHPC. We also compared the same factors among the prehepatectomy, synchronous, and posthepatectomy groups. Different types of extrahepatic cancers were also investigated in detail.
Gastric and colorectal cancers were the most common EHPC. No definite relationship was observed between HCC and other specific cancers such as B-cell lymphoproliferative disorders. There also were no differences in either the liver function tests, alpha-fetoprotein, or prognostic pathological indicators such as portal vein invasion and intrahepatic metastases. In addition, we found no difference in patient survival between the patients with and without EHPC. However, disease-free survival rates in patients with EHPC were significantly higher than in those without EHPC. Patients in the prehepatectomy group were older than those in the synchronous and posthepatectomy groups, and no positive hepatitis B surface antigen was found in the prehepatectomy group. Patient survival was significantly higher in the posthepatectomy group than in the prehepatectomy group; however, no significant difference in disease-free survival was found among the three groups. Only one patient died of EHPC.
No specific clinicopathological factors were observed in patients with HCC associated with EHPC. Furthermore, EHPC had no adverse effect on either patient survival or disease-free survival after hepatic resection. The predominant cancer was gastric cancer, whereas the most frequent cause of death was HCC itself. Therefore, a strict follow-up of HCC--as well as screening for the most common cancers, such as gastric cancers in southern Japan--should be required for patients with HCC associated with EHPC.
本研究旨在阐明与肝细胞癌(HCC)相关的肝外原发性癌(EHPC)患者的特征,并探讨EHPC对肝切除术后患者生存及无病生存的影响。
纳入463例行肝切除患者中的41例。比较有和无EHPC患者的临床病理因素,包括生存情况。我们还比较了肝切除术前、同步和肝切除术后组的相同因素。对不同类型的肝外癌也进行了详细研究。
胃癌和结直肠癌是最常见的EHPC。未观察到HCC与其他特定癌症如B细胞淋巴增殖性疾病之间存在明确关系。肝功能检查、甲胎蛋白或预后病理指标如门静脉侵犯和肝内转移方面也无差异。此外,有和无EHPC患者的生存情况无差异。然而,EHPC患者的无病生存率显著高于无EHPC患者。肝切除术前组患者比同步和肝切除术后组患者年龄大,且肝切除术前组未发现乙肝表面抗原阳性。肝切除术后组患者的生存情况显著高于肝切除术前组;然而,三组间无病生存无显著差异。仅1例患者死于EHPC。
在与EHPC相关的HCC患者中未观察到特定的临床病理因素。此外,EHPC对肝切除术后患者生存及无病生存均无不良影响。主要癌症为胃癌,而最常见的死亡原因是HCC本身。因此,对于与EHPC相关的HCC患者,应严格随访HCC,并筛查最常见的癌症,如日本南部的胃癌。